Abstract:Subclinical hypothyroidism (SH) is generally an asymptomatic condition defined as normal serum levels of thyroid hormones (free triiodothyronine [FT3] and free thyroxine [FT4]) and elevated thyroid stimulating hormone (TSH) levels. In the majority of cases, the etiology is represented by chronic autoimmune thyroiditis, as Hashimoto's thyroiditis. It is well known that thyroid hormones have a fundamental role on heart function, mediated by both genomic and non-genomic effects. Indeed, thyroid hormone deficiency results in lower heart rate and weakening of myocardial contraction, with prolonged early diastolic and systolic times. One of the most important aspects, in most cases underestimate in young patients without cardiovascular (CV) comorbidities, is the left ventricular diastolic dysfunction (LVDD) [ [1] Vargas-Uricoechea H. Bonelo-Perdomo A. Sierra-Torres C.H. Effects of thyroid hormones on the heart. Clin. Investig. Arterioscler. 2014; 26: 296-309 Crossref PubMed Scopus (74) Google Scholar ]. An impairment in diastolic function is a common clinical finding in daily clinical practice; moreover, it could be the prelude to more serious cardiac impairment, given that LVDD often precedes and/or causes systolic dysfunction. Previous studies reported that LVVDD is a frequent finding in patient with stable SH. Actually, the underlying pathology mechanism seems to be the reduction in calcium re-uptake into sarcoplasmatic reticulum trough decreased expression of sarcoplasmatic reticulcum calcium ATPase (SERCA) and phosholamban activation. Wassen and colleagues also identified type-3 deiodinase upregulation in cardiac tissue, which is able to convert inactive T3 to its active form. Moreover, type 3 deiodinase is generally stimulated by interleukin-6 (IL-6) and tumor necrosis factor alfa (TNF-α), which are related to LVDD [ [2] Masaki M. Komamura K. Goda A. Hirotani S. Otsuka M. Nakabo A. et al. Elevated arterial stiffness and diastolic dysfunction in subclinical hypothyroidism. Circ. J. 2014; 78: 1494-1500 Crossref PubMed Scopus (34) Google Scholar ]. The association between SH and cardiac consequences raises some questions: 1.Is echocardiographic assessment useful in these subjects? 2.What is the best therapeutic strategy?

Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function

Left Ventricular Diastolic Dysfunction in Young Patients with Subclinical Hypothyroidism: to Screen or Not to Screen? to Treat or Not to Treat?

Does subclinical hypothyroidism affect the prognosis of patients with chronic systolic heart failure: A systematic review and meta-analysis

Subclinical Hypothyroidism in Geriatric Population and Its Association With Heart Failure

Cardiovascular and atherogenic aspects of subclinical hypothyroidism

Mechanism of subclinical hypothyroidism accelerating endothelial dysfunction (Review).

Effect of levothyroxine replacement therapy in patients with subclinical hypothyroidism and chronic heart failure: A systematic review

Association of Thyroid Dysfunction in Individuals ≥ 65 Years of Age With Subclinical Cardiac Abnormalities

Subclinical hypothyroidism is an independent predictor of adverse cardiovascular outcomes in patients with acute decompensated heart failure

Subclinical Thyroid Dysfunction is Associated with Adverse Prognosis in Heart Failure Patients with Reduced Ejection Fraction

Subclinical hypothyroidism: a new predictor of heart failure with improved ejection fraction in HFrEF patients

An Assessment of Cardiac Risk Factors on Subclinical Hypothyroidism in Coronary Heart Disease Patients

The Role of Subclinical Hypothyroidism in the Pathogenesis and Course of Chronic Heart Failure

The impact of thyroid hormone replacement therapy on left ventricular diastolic function in patients with subclinical hypothyroidism

Efficacy and safety of thyroxine therapy on patients with heart failure and subclinical hypothyroidism: A protocol for systematic review and meta-analysis

Non-invasive markers of cardiovascular risk in patients with subclinical hypothyroidism: A systematic review and meta-analysis of 27 case control studies

Subclinical hypothyroidism predicts outcome in heart failure: insights from the T.O.S.CA. registry

Hypothyroidism and metabolic cardiovascular disease

Subclinical hypothyroidism or isolated high TSH in hospitalized patients with chronic heart-failure and chronic renal-failure

High Thyroid-Stimulating Hormone Level is Associated with the Risk of Developing Atherosclerosis in Subclinical Hypothyroidism

Hypothyroidism and Risk of Cardiovascular Disease.